NCM
NPCE icon

Nantahala Capital Management’s Neuropace NPCE Stock Holding History

Nantahala Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-295,089
Closed -$4.56M – 170
2025
Q4 		$4.56M Hold
295,089
– – 0.15% 103
2025
Q3 		$3.04M Hold
295,089
– – 0.11% 120
2025
Q2 		$3.29M Sell
295,089
-17,005
-5% -$213K 0.13% 109
2025
Q1 		$3.84M Sell
312,094
-249,979
-44% -$3.13M 0.15% 85
2024
Q4 		$6.29M Sell
562,073
-45,817
-8% -$398K 0.27% 67
2024
Q3 		$4.24M Sell
607,890
-8,933
-1% -$65.3K 0.21% 79
2024
Q2 		$4.66M Sell
616,823
-161,437
-21% -$1.63M 0.27% 64
2024
Q1 		$10.3M Sell
778,260
-395,417
-34% -$5.64M 0.59% 36
2023
Q4 		$12.1M Sell
1,173,677
-46,238
-4% -$369K 0.72% 26
2023
Q3 		$11.9M Buy
1,219,915
+795,065
+187% +$4.66M 1.01% 19
2023
Q2 		$1.91M Sell
424,850
-1,075
-0.3% -$4.86K 0.18% 78
2023
Q1 		$1.98M Sell
425,925
-7,657
-2% -$29.3K 0.15% 75
2022
Q4 		$646K Sell
433,582
-9,920
-2% -$22K 0.04% 95
2022
Q3 		$1.66M Sell
443,502
-34,936
-7% -$168K 0.11% 78
2022
Q2 		$2.37M Sell
478,438
-6,865
-1% -$45.3K 0.12% 78
2022
Q1 		$3.98M Buy
485,303
+179,397
+59% +$1.55M 0.18% 69
2021
Q4 		$3.08M Buy
305,906
+164,265
+116% +$2.13M 0.11% 93
2021
Q3 		$2.25M Sell
141,641
-5,763
-4% -$121K 0.07% 102
2021
Q2 		$3.51M Buy
+147,404
New +$3.42M 0.1% 100

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Nantahala Capital Management's NPCE Position: Q1 2026 in Review

Nantahala Capital Management sold out of Neuropace (NPCE) in Q1 2026, closing a stake of 295,089 shares — an estimated $4.56M sold.

Nantahala Capital Management first reported a position in NPCE in Q2 2021 and held it in 19 quarters. The position peaked at $12.1M in Q4 2023. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Nantahala Capital Management reported no remaining Neuropace position as of Q1 2026 after selling out during the quarter.
  • Nantahala Capital Management sold 295,089 Neuropace shares in Q1 2026, an estimated $4.56M.
  • Nantahala Capital Management first reported a position in Neuropace in Q2 2021 and held it in 19 quarters.
  • Nantahala Capital Management's Neuropace position peaked at $12.1M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.